Wolves living inside the Chernobyl Exclusion Zone show genetic and immune-system signals that researchers say may be linked ...

A new study highlights racial disparities in a subset of cancer patients and, using advanced biomedical research technology, provides evidence for those differences at the molecular level. "Precision ...

Richardson, MD, gave an overview of the ways that CELMoDs are poised to impact the landscape of multiple myeloma treatment at various stages of disease treatment. At the Miami Cancer Institute’s ...

Psychologists share what 'catastrophizing' really means and how to combat it.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...

In this video, Coral Omene, MD, PhD, assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, and program director of Breast Cancer Disparities Research in the division of ...

As hospitals reduced their spending on oncology treatments due to the increasing availability of biosimilars, the reimbursements they received from insurers did not drop at the same rate—allowing h | ...

A new analysis suggests many anti-aging claims may reflect disease-specific improvements rather than genuine slowing of aging ...

Explore Manoj K Jayan's Pisces horoscope covering love, health, and career with practical guidance for steady, meaningful ...

Patients who received narrative-based palliative care also reported better quality of life, improved sleep quality, and greater acceptance of death compared with patients receiving routine care. These ...

First-in-class immune-stimulating antibody conjugate BDC-4182 in Phase 1 dose escalation study, initial clinical data expected in 3Q 2026 Cash balance of $31.8 million as of December 31, 2025 ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...